Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
ASL
0.43%
$1.17
ANDEAN SILVER LIMITED - Corporate Spotlight
Market Cap $164.3M
!
Add to my watchlist
No Corporate Spotlight currently available.